The startup will be headed by CEO Ron Renaud, who previously led Cerevel Therapeutics — a developer of drugs for neurological conditions — and oversaw its acquisition by AbbVie in an $8.7 billion deal ...

Letitia Dean looked in good spirits as she had a helping hand while making a giddy exit from the Inside Soap Awards on Monday night.

So apparently there's this new drug that makes you lose a lot of weight. Have you heard about it? So Ozempic was originally ...

Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup ...

Fueled by the rise of the blockbuster GLP-1 drugs, including Ozempic and Wegovy, thinness appears to be making a comeback in ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

Four in 10 people are thought to have a potentially serious liver condition known as MASLD. Reversing it is possible if you ...

A series of state and federal lawsuits challenging coverage exclusions for obesity drugs and procedures are testing the ...

In a leadership shakeup, the diet company says CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...

We know there are several physical risks associated with the drugs, but some are now beginning to question whether there are ...

Time-restricted eating may improve blood glucose control and help reduce fat when coupled with standard nutritional ...

An analyst waxed bullish on the company's leading pipeline program.